抗风湿药

目的探讨柳氮磺吡啶（SSZ）、雷公藤多甙（T2）、甲氨蝶呤（MTX）等缓作用抗风湿药在强直性脊柱炎（AS）治疗中的地位。

Objective The efficacy of slow acting antirheumatic drugs ( SAARDs ) including sulfasalazine ( SSZ ), tripterygium glycosides ( T2 ), methotrexate ( MTX ) in ankylosing spondylitis ( AS ) .

两种慢作用抗风湿药联合治疗类风湿关节炎临床观察

Clinical observation on slow-acting antirheumatic drugs combination on rheumatoid arthritis

目前，改善症状、减慢疾病进展的抗风湿药是RA的主要治疗手段。

Now the main therapeutic tool is the anti-rheumatic drugs , that can abatement symptom and step down the progression .

提示：MTX治疗RA有缓解病情抗风湿药（DMARDs）作用。

Conclusion : There were disease modifying anti rheumatic drugs ( DMARDs ) in the treatment of RA with MTX .

现代临床西药治疗RA主要采用非甾体抗炎药、慢作用抗风湿药、肾上腺皮质激素类等药物，总体上治愈率，副作用大。

Modern Western medicine treatment of RA the main clinical use of non-steroidal anti-inflammatory drugs , slow-acting anti-rheumatic drugs , adrenal cortex hormones , such as drugs , the overall cure rate , side effects .

40例RA患者使用慢作用抗风湿药（DMARD）治疗9个月后，其尿液D-Pyd浓度水平均较起始时下降（P<0.001）。

The urinary levels of D-Pyd were found to be significantly reduced by 9 months than baseline in 40 cases with active RA were treated with DMARD .

用抗风湿药或抗生素类药治疗无效。

With anti-rheumatic drugs or antibiotics are ineffective treatment class medicine .

改善病情抗风湿药联合治疗类风湿性关节炎的疗效及安全性比较

Comparison of Efficacy and Safety of Different DMARDs Combination Therapies for Rheumatoid Arthritis

结论大剂量胸腺肽可作为慢作用抗风湿药的替代或补充。

Conclusion High dose thymosine can be an alternative or complemented agent of the slow-action anti-rheumatic drugs .